Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic

Seminars in Cancer Biology

Volumn 7, Issue 3, 1996, Pages 147-154

  Stetler Stevenson, William G ^a   Hewitt, Robert ^a   Corcoran, Marta ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Extracellular matrix; Invasion; Metastases; Proteases; TIMPs

Indexed keywords

BATIMASTAT; COLLAGENASE; CYTOSTATIC AGENT; ELASTASE; GELATINASE; ILOMASTAT; MARIMASTAT; METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; CANCER INVASION; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; EFFUSION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; ORAL DRUG ADMINISTRATION; PROTEIN EXPRESSION; REVIEW; TUMOR CELL; WOUND HEALING;

EID: 0029903248     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0020     Document Type: Review

References (58)

1. Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573
2. Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG, Lala PK (1994) Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res 214:93-99
3. Ray JM, Stetler-Stevenson WG (1994) The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur Resp J 7:2062-2072
4. Ray JM, Stetler-Stevenson WG (1995) Gelatinase-a activity directly modulates melanoma cell-adhesion and spreading. EMBO J 14:908-917
5. Seftor RE, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJ (1992) Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89:1557-1561
6. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250
7. Van Wart H, Birkedal HH (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578-5582
8. Pei D, Weiss SJ (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375:244-247
9. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P (1995) Membrane-type matrix metalloproteinase (MT-MPP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734
10. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 370:61-65
11. Takino T, Sato H, Shinagawa A, Seiki M (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placental cDNA library. J Biol Chem 270:23013-23020
12. Will B, Hinzmann B (1995) Eur J Biochem 231:602-608
13. Wilde CG, Hawkins PR, Coleman RT, Levine WB, Delegeane AM, Okamoto PM, Ito LY, Scott RW, Seilhamer JJ (1994) Cloning and characterization of human tissue inhibitor of metalloproteinases-3. DNA Cell Biol 13:711-718
14. Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). J Biol Chem 264:17374-17378
15. Apte SS, Olsen BR, Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (timp)-3 and its inhibitory activities define the distinct timp gene family. J Biol Chem 270:14313-14318
16. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269:9352-9360
17. Yang B, Hall CL, Yang BL, Savani RC, Turley EA (1994) Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells. J Cell Biochem 56:455-468
18. DeClerck YA, Yean TD, Lee Y, Tomich JM, Langley KE (1993) Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem J 289:65-69
19. Williamson R, Marston F, Angal S, Koklitis PO, Panico M, Morris H, Carne A, Smith B, Harris T, Freedman R (1990) Bisulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 268:267-274
20. Stetler-Stevenson WG, Liotta LA, Kleiner D Jr (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. Faseb J 7:1434-1441
21. Kleiner D Jr, Stetler-Stevenson WG (1993) Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 5:891-897
22. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetler-Stevenson WG (1992) Domain structure of human 72-kDa gelatinase/ type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 267:15398-15405
23. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJ (1992) The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases [published erratum appears in Biochem J (1992) Jun 15;284 (Pt 3):935]. Biochem J 283:637-641
24. Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G (1994) Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A. Biochemistry 33:2089-2095
25. Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G (1993) The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 32:4330-4337
26. Kolkenbrock H, Hecker-Kia A, Orgel D, Ruppitsch W, Ulbrich N (1994) Activity of ternary gelatinase A-TIMP-2-matrix metallo-proteinase complexes. Biol Chem Hoppe Seyler 375:589-595
27. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinoma. Nature 348:699-704
28. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66:1188-1194
29. Urbanski SJ, Edwards DR, Hershfield N, Huchcroft SA, Shaffer E, Sutherland L, Kossakowska AE (1993) Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol 2:81-89
30. Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio MC, Eber M, Methlin G et al (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53:165-169
31. Majmudar G, Nelson BR, Jensen TC, Voorhees JJ, Johnson TM (1994) Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinogen 9:17-23
32. Pei D, Majmudar G, Weiss SJ (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269:25849-25855
33. Kusukawa J, Sasaguri X Shima I, Kameyama T, Morimatsu M (1993) Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 99:18-23
34. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG (1990) Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585-592
35. Brown PD, Bloxidge RE, Anderson E, Howell A (1993) Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11:183-189
36. Brown PD, Bloxidge RE, Stuart NS, Gatter KC, Carmichael J (1993) Association between expression of activated 72-kilo-dalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85:574-578
37. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts [published erratum appears in Cancer Res (1993) Aug 1;53(15):3652]. Cancer Res 53:2087-2091
38. Azzam HS, Arand G, Lippman ME, Thompson EW (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85:1758-1764
39. Emmert-Buck MR, Roth MJ, Zhuan Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG (1994) Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145:1285-1290
40. Boag AH, Young ID (1994) Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am J Pathol 144:585-591
41. Nomura H, Sato H, Seiki M, Mai M, Okada Y (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266
42. Ponton A, Coulombe B, Skup D (1991) Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 51:2138-2143
43. Testa JE (1992) Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Cancer Res 52:5597-5603
44. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, Seiki M (1993) Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 53:1397-1402
45. Khokha R (1994) Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86:299-304
46. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P (1992) Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84:1017-1022
47. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibitor of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708
48. Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA (1994) Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54:5467-5473
49. Falkson G, Gelman R, Glick J, Falkson CI, Harris J (1994) Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 12:4549
50. Huynh HT, Tetenes E, Wallace L, Pollak M (1993) In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res 53:1727-1730
51. Brown PD (1994) Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer. Ann NY Acad Sci 732:217-221
52. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM (1994) Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54:47264-728
53. Naito K, Kanbayashi N, Nakajima S, Murai T, Arakawa K, Nishimura S, Okuyama A (1994) Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer 58:730-735
54. Okuyama A, Naito K, Morishima H, Suda H, Nishimura S, Tanaka N (1994) Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Ann NY Acad Sci 732:408-410
55. Tressler RJ, Wee J, Summers B, Galardy R (1994) Galardin, a potent metalloproteinase inhibitor, prolongs survival time in a B16-F10 melanoma experimental metastasis model. Clin Exp Metastasis 12:28
56. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Sacanziani E, Brown PD, Giavazzi R (1995) Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Nat Cancer Inst 87:293-298
57. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA (1994) Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)4-methylpentanoyl)]-L-tryptoph-an methylamide. Cancer Res 54:4715-4718
58. Drummond AH, Beckett P, Boone EA, Brown PD, Davis M, Galloway WA, Taupin P, Wood LM, Davidson AH (1995) BB-2516: An orally bioavailable matrix metalloproteinase inhibitor with efficacy in animal cancer models. Proc Am Assoc Cancer Res 36:100